Soluble Amyloid-beta Aggregates from Human Alzheimer's Disease Brains. 2016

Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
Department of Neurology, 660 South Euclid Avenue, Box 8111, Washington University, St. Louis, Missouri, USA.

Soluble amyloid-beta (Aβ) aggregates likely contribute substantially to the dementia that characterizes Alzheimer's disease. However, despite intensive study of in vitro preparations and animal models, little is known about the characteristics of soluble Aβ aggregates in the human Alzheimer's disease brain. Here we present a new method for extracting soluble Aβ aggregates from human brains, separating them from insoluble aggregates and Aβ monomers using differential ultracentrifugation, and purifying them >6000 fold by dual antibody immunoprecipitation. The method resulted in <40% loss of starting material, no detectible ex vivo aggregation of monomeric Aβ, and no apparent ex vivo alterations in soluble aggregate sizes. By immunoelectron microscopy, soluble Aβ aggregates typically appear as clusters of 10-20 nanometer diameter ovoid structures with 2-3 amino-terminal Aβ antibody binding sites, distinct from previously characterized structures. This approach may facilitate investigation into the characteristics of native soluble Aβ aggregates, and deepen our understanding of Alzheimer's dementia.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D001923 Brain Chemistry Changes in the amounts of various chemicals (neurotransmitters, receptors, enzymes, and other metabolites) specific to the area of the central nervous system contained within the head. These are monitored over time, during sensory stimulation, or under different disease states. Chemistry, Brain,Brain Chemistries,Chemistries, Brain
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D016229 Amyloid beta-Peptides Peptides generated from AMYLOID BETA-PEPTIDES PRECURSOR. An amyloid fibrillar form of these peptides is the major component of amyloid plaques found in individuals with Alzheimer's disease and in aged individuals with trisomy 21 (DOWN SYNDROME). The peptide is found predominantly in the nervous system, but there have been reports of its presence in non-neural tissue. Alzheimer beta-Protein,Amyloid Protein A4,Amyloid beta-Peptide,Amyloid beta-Protein,beta Amyloid,beta-Amyloid Protein,Alzheimer's ABP,Alzheimer's Amyloid Fibril Protein,Amyloid AD-AP,Amyloid Fibril Protein, Alzheimer's,Amyloid beta-Proteins,ABP, Alzheimer's,AD-AP, Amyloid,Alzheimer ABP,Alzheimer beta Protein,Alzheimers ABP,Amyloid AD AP,Amyloid beta Peptide,Amyloid beta Peptides,Amyloid beta Protein,Amyloid beta Proteins,Amyloid, beta,Protein A4, Amyloid,Protein, beta-Amyloid,beta Amyloid Protein,beta-Peptide, Amyloid,beta-Peptides, Amyloid,beta-Protein, Alzheimer,beta-Protein, Amyloid,beta-Proteins, Amyloid
D066263 Protein Aggregation, Pathological A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS. Aggregation, Pathological Protein,Pathological Protein Aggregation

Related Publications

Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
June 1997, FEBS letters,
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
September 2022, Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics,
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
January 2021, Brain communications,
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
December 2021, Cell & bioscience,
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
July 2022, Brain : a journal of neurology,
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
July 1987, Science (New York, N.Y.),
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
June 2000, Biochemistry,
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
November 1998, Angewandte Chemie (International ed. in English),
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
October 1987, Science (New York, N.Y.),
Thomas J Esparza, and Norelle C Wildburger, and Hao Jiang, and Mihika Gangolli, and Nigel J Cairns, and Randall J Bateman, and David L Brody
February 2023, The journal of physical chemistry letters,
Copied contents to your clipboard!